301507 民生健康
已收盘 11-15 15:00:00
资讯
新帖
简况
【机构调研记录】海富通基金调研民生健康、德赛西威等3只个股（附名单）
证券之星 · 11-06
【机构调研记录】海富通基金调研民生健康、德赛西威等3只个股（附名单）
民生健康：方正证券、华夏基金等多家机构于11月4日调研我司
证券之星 · 11-05
民生健康：方正证券、华夏基金等多家机构于11月4日调研我司
民生健康（301507）2024年三季报简析：营收净利润同比双双增长
证券之星 · 10-30
民生健康（301507）2024年三季报简析：营收净利润同比双双增长
民生健康(301507.SZ)发布前三季度业绩，净利润8617.84万元，增长5.52%
智通财经 · 10-28
民生健康(301507.SZ)发布前三季度业绩，净利润8617.84万元，增长5.52%
图解民生健康三季报：第三季度单季净利润同比减23.33%
证券之星 · 10-28
图解民生健康三季报：第三季度单季净利润同比减23.33%
民生健康(301507)9月30日股东户数2.65万户，较上期减少2.78%
证券之星 · 10-28
民生健康(301507)9月30日股东户数2.65万户，较上期减少2.78%
民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股
智通财经 · 09-18
民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股
民生健康:辅导券商保荐人监管处罚，公司考虑继续聘用吗？
问董秘 · 09-12
民生健康:辅导券商保荐人监管处罚，公司考虑继续聘用吗？
民生健康:辅导券商尽职尽责，公司保守稳健，无更换保荐人打算
问董秘 · 09-12
民生健康:辅导券商尽职尽责，公司保守稳健，无更换保荐人打算
上市一年市值跌逾六成，民生健康仍依赖大单品“21金维他”
蓝鲸财经 · 09-09
上市一年市值跌逾六成，民生健康仍依赖大单品“21金维他”
【机构调研记录】华夏基金调研民生健康、航天彩虹等8只个股（附名单）
证券之星 · 09-06
【机构调研记录】华夏基金调研民生健康、航天彩虹等8只个股（附名单）
上市一周年 民生健康围绕“四新战略”打造四个运营平台
上海 · 09-05
上市一周年 民生健康围绕“四新战略”打造四个运营平台
民生健康：财通证券、华鑫证券等多家机构于9月3日调研我司
证券之星 · 09-05
民生健康：财通证券、华鑫证券等多家机构于9月3日调研我司
民生健康（301507）2139.33万股限售股将于9月5日解禁，占总股本6%
证券之星 · 09-05
民生健康（301507）2139.33万股限售股将于9月5日解禁，占总股本6%
民生健康(301507.SZ)2139.33万股限售股将于9月5日上市流通
智通财经 · 09-02
民生健康(301507.SZ)2139.33万股限售股将于9月5日上市流通
民生健康（301507）2024年中报简析：营收净利润同比双双增长
证券之星 · 08-30
民生健康（301507）2024年中报简析：营收净利润同比双双增长
图解民生健康中报：第二季度单季净利润同比增24.48%
证券之星 · 08-29
图解民生健康中报：第二季度单季净利润同比增24.48%
民生健康最新公告：拟推350万股限制性股票激励计划
证券之星 · 08-28
民生健康最新公告：拟推350万股限制性股票激励计划
民生健康(301507.SZ)发上半年业绩，净利润7726.94万元，同比增长10.30%
智通财经 · 08-28
民生健康(301507.SZ)发上半年业绩，净利润7726.94万元，同比增长10.30%
民生健康最新公告：上半年净利润7726.94万元 同比增长10.30%
证券之星 · 08-28
民生健康最新公告：上半年净利润7726.94万元 同比增长10.30%
加载更多
公司概况
公司名称：
杭州民生健康药业股份有限公司
所属行业：
医药制造业
上市日期：
2023-09-05
主营业务：
杭州民生健康药业股份有限公司的主营业务是集维生素与矿物质类非处方药品和保健食品研发、生产、销售。公司的主要产品是维生素与矿物质补充剂系列产品和益生菌系列产品；经过十余年的行业深耕，公司构建了覆盖全国的终端销售网络体系，拥有较强的品牌知名度和美誉度。公司主打品牌“21金维他”，2019年上榜“健康中国品牌榜”西普金·奖锐榜，2020年上榜“健康中国·品牌榜”西普金奖药品榜，2021年度入选“2020-2021年健康产业·品牌发展指数·TOP品牌”。
发行价格：
10.00
{"stockData":{"symbol":"301507","market":"SZ","secType":"STK","nameCN":"民生健康","latestPrice":13.38,"timestamp":1731654189000,"preClose":13.73,"halted":0,"volume":5048051,"delay":0,"floatShares":111000000,"shares":357000000,"eps":0.2529,"marketStatus":"已收盘","marketStatusCode":5,"change":-0.35,"latestTime":"11-15 15:00:00","open":13.75,"high":13.87,"low":13.35,"amount":68874100,"amplitude":0.0379,"askPrice":13.39,"askSize":100,"bidPrice":13.38,"bidSize":5,"shortable":0,"etf":0,"ttmEps":0.2529,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1731893400000},"adr":0,"adjPreClose":13.73,"symbolType":"stock","openAndCloseTimeList":[[1731634200000,1731641400000],[1731646800000,1731654000000]],"highLimit":15.1,"lowLimit":12.36,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":356554330,"pbRate":3.21,"roa":"--","roe":"5.73%","epsLYR":0.29,"committee":0.281749,"marketValue":4771000000,"floatMarketCap":1479000000,"peRate":52.906286,"changeRate":-0.0255,"turnoverRate":0.0457,"status":1},"requestUrl":"/m/hq/s/301507","defaultTab":"news","newsList":[{"id":"2481664640","title":"【机构调研记录】海富通基金调研民生健康、德赛西威等3只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2481664640","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481664640?lang=zh_cn&edition=full","pubTime":"2024-11-06 08:04","pubTimestamp":1730851469,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及11月5日披露的机构调研信息，海富通基金近期对3家上市公司进行了调研，相关名单如下：1）民生健康 个股亮点：公司销售的主要产品品种为多维元素片、多种维生素矿物质片、益生菌系列保健食品和食品等。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110600007727.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507","BK0264","002920"],"gpt_icon":0},{"id":"2481512382","title":"民生健康：方正证券、华夏基金等多家机构于11月4日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2481512382","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2481512382?lang=zh_cn&edition=full","pubTime":"2024-11-05 12:57","pubTimestamp":1730782627,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年11月5日民生健康发布公告称方正证券王泽华 谌保罗 毛学东、华夏基金李柄桦、东方证券邢恺、海富通基金陈涛、瓦琉咨询陈哲毅于2024年11月4日调研我司。民生健康主营业务：维生素与矿物质类非处方药品和保健食品研发、生产、销售。融资融券数据显示该股近3个月融资净流入455.86万，融资余额增加；融券净流出18.78万，融券余额减少。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024110500018153.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0122","BK0276","BK0183","BK0012","BK0239","601901","301507","BK0028","BK0188"],"gpt_icon":0},{"id":"2479402261","title":"民生健康（301507）2024年三季报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2479402261","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2479402261?lang=zh_cn&edition=full","pubTime":"2024-10-30 06:37","pubTimestamp":1730241451,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期民生健康发布2024年三季报。根据财报显示，民生健康营收净利润同比双双增长。截至本报告期末，公司营业总收入5.2亿元，同比上升6.99%，归母净利润8617.84万元，同比上升5.52%。按单季度数据看，第三季度营业总收入1.22亿元，同比上升3.65%，第三季度归母净利润890.9万元，同比下降23.33%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024103000007554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2478748941","title":"民生健康(301507.SZ)发布前三季度业绩，净利润8617.84万元，增长5.52%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478748941","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478748941?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:30","pubTimestamp":1730107804,"startTime":"0","endTime":"0","summary":"智通财经APP讯，民生健康(301507.SZ)发布2024年三季度报告，该公司前三季度营业收入为5.2亿元，同比增长6.98%。归属于上市公司股东的净利润为8617.84万元，同比增长5.52%。归属于上市公司股东的扣除非经常性损益的净利润为8237.56万元，同比增长9.30%。基本每股收益为0.24元。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1201329.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507"],"gpt_icon":0},{"id":"2478953171","title":"图解民生健康三季报：第三季度单季净利润同比减23.33%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478953171","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478953171?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:19","pubTimestamp":1730107164,"startTime":"0","endTime":"0","summary":"证券之星消息，民生健康2024年三季报显示，公司主营收入5.2亿元，同比上升6.99%；归母净利润8617.84万元，同比上升5.52%；扣非净利润8237.56万元，同比上升9.3%；其中2024年第三季度，公司单季度主营收入1.22亿元，同比上升3.65%；单季度归母净利润890.9万元，同比下降23.33%；单季度扣非净利润781.82万元，同比下降23.39%；负债率10.8%，投资收益423.97万元，财务费用-1668.51万元，毛利率57.47%。财报数据概要请见下图:以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800023419.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2478119179","title":"民生健康(301507)9月30日股东户数2.65万户，较上期减少2.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2478119179","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2478119179?lang=zh_cn&edition=full","pubTime":"2024-10-28 17:09","pubTimestamp":1730106555,"startTime":"0","endTime":"0","summary":"证券之星消息，近日民生健康披露，截至2024年9月30日公司股东户数为2.65万户，较6月30日减少757.0户，减幅为2.78%。在化学制药行业个股中，民生健康股东户数低于行业平均水平，截至9月30日，化学制药行业平均股东户数为3.14万户。从股价来看，2024年6月30日至2024年9月30日，民生健康区间涨幅为11.49%，在此期间股东户数减少757.0户，减幅为2.78%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024102800022868.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2468858589","title":"民生健康(301507.SZ)授出332万股限制性股票 授予价为6.67元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2468858589","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2468858589?lang=zh_cn&edition=full","pubTime":"2024-09-18 20:32","pubTimestamp":1726662765,"startTime":"0","endTime":"0","summary":"智通财经APP讯，民生健康(301507.SZ)公告，公司于2024年9月18日向2024年限制性股票激励计划激励对象首次授予限制性股票332万股，授予价格为6.67元/股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1184279.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2466226919","title":"民生健康:辅导券商保荐人监管处罚，公司考虑继续聘用吗？","url":"https://stock-news.laohu8.com/highlight/detail?id=2466226919","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466226919?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:17","pubTimestamp":1726132620,"startTime":"0","endTime":"0","summary":"炒股就看金麒麟分析师研报，权威，专业，及时，全面，助您挖掘潜力主题机会！ 投资者提问：公开信息显示，公司辅导券商的保荐人近三年内有受过监管处罚，请问公司是否考虑继续聘用。董秘回答(民生健康SZ301507)：尊敬的投资者您好，感谢对公司的关注。根据《深圳证券交易所创业板股票上市规则》等有关规定，首次公开发行股票的，保荐机构持续督导期间为股票上市当年剩余时间及其后三个完整会计年度，保荐机构履行持续督导职责符合相关规定，谢谢！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuk7570189.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuk7570189.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2466226948","title":"民生健康:辅导券商尽职尽责，公司保守稳健，无更换保荐人打算","url":"https://stock-news.laohu8.com/highlight/detail?id=2466226948","media":"问董秘","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466226948?lang=zh_cn&edition=full","pubTime":"2024-09-12 17:14","pubTimestamp":1726132440,"startTime":"0","endTime":"0","summary":"投资者提问：上市之后辅导券商是否尽职尽责，感觉公司这几年都比较保守，是否有更换辅导券商的打算董秘回答(民生健康SZ301507)：尊敬的投资者您好，感谢对公司的关注。保荐机构和保荐代表人在持续督导期间已根据证监会及交易所有关制度规定正常履行持续督导职责，公司无更换保荐人的打算，谢谢！查看更多董秘问答>>免责声明：本信息由新浪财经从公开信息中摘录，不构成任何投资建议；新浪财经不保证数据的准确性，内容仅供参考。\n\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuq3189963.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/dongmiqa/2024-09-12/doc-incnwvuq3189963.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2466619629","title":"上市一年市值跌逾六成，民生健康仍依赖大单品“21金维他”","url":"https://stock-news.laohu8.com/highlight/detail?id=2466619629","media":"蓝鲸财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2466619629?lang=zh_cn&edition=full","pubTime":"2024-09-09 22:09","pubTimestamp":1725890940,"startTime":"0","endTime":"0","summary":"1985年，民生健康推出多维元素片，并依托21金维他推出了多种维生素矿物质片保健食品及食品。2021年至2023年，21金维他的销售收入分别4.76亿元、4.39亿元、4.23亿元，占公司当期主营业务收入的比重分别为82.05%，80.46%、86.70%。从产品来看，2024年上半年，公司在多种维生素矿物质片保健食品及食品实现了较大增长，但21金维他仍贡献了近八成收入。为打破产品单一的情况，民生健康大力促进新品研发。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-09/doc-incnqrfh9631131.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-09/doc-incnqrfh9631131.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2465668334","title":"【机构调研记录】华夏基金调研民生健康、航天彩虹等8只个股（附名单）","url":"https://stock-news.laohu8.com/highlight/detail?id=2465668334","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465668334?lang=zh_cn&edition=full","pubTime":"2024-09-06 08:01","pubTimestamp":1725580883,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及9月5日披露的机构调研信息，华夏基金近期对8家上市公司进行了调研，相关名单如下：1）民生健康 个股亮点：公司销售的主要产品品种为多维元素片、多种维生素矿物质片、益生菌系列保健食品和食品等。华夏基金成立于1998年，截至目前，资产管理规模14832.88亿元，排名2/207；资产管理规模9232.61亿元，排名2/207；管理公募基金数793只，排名1/207；旗下公募基金经理124人，排名1/207。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090600005690.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","002389","BK0102","301507","BK0128","BK0239","BK0070","BK0214","BK0028"],"gpt_icon":0},{"id":"2465542063","title":"上市一周年 民生健康围绕“四新战略”打造四个运营平台","url":"https://stock-news.laohu8.com/highlight/detail?id=2465542063","media":"上海","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465542063?lang=zh_cn&edition=full","pubTime":"2024-09-05 21:24","pubTimestamp":1725542640,"startTime":"0","endTime":"0","summary":"公司围绕“四新战略”，打造了健康药业、民生医药、民生同春和健康科技四个运营平台：健康药业是以“21金维他”为核心的平台；民生医药是以大单品战略为目标的平台；民生同春是大健康产品平台；健康科技是集益生菌原料、生产加工、品牌运营一体化的平台。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-05/doc-incnckph5621133.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2024-09-05/doc-incnckph5621133.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2465756244","title":"民生健康：财通证券、华鑫证券等多家机构于9月3日调研我司","url":"https://stock-news.laohu8.com/highlight/detail?id=2465756244","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465756244?lang=zh_cn&edition=full","pubTime":"2024-09-05 10:54","pubTimestamp":1725504853,"startTime":"0","endTime":"0","summary":"证券之星消息，2024年9月5日民生健康发布公告称财通证券、华鑫证券、开源证券、证券时报、上海证券报、中国证券报、证券日报、经济参考报、中国经营报、香港经济导报、临平报社、方正证券、浙江在线、界面、财联社、21 世纪经济报道、第一财经、经济观察报、南方都市报、经济日报、每日经济新闻、华福证券、招商证券、华夏基金、平安证券、甬兴证券、中信证券、国海证券于2024年9月3日调研我司。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500012886.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["601108","BK0276","301507","BK0239","161027"],"gpt_icon":0},{"id":"2465554338","title":"民生健康（301507）2139.33万股限售股将于9月5日解禁，占总股本6%","url":"https://stock-news.laohu8.com/highlight/detail?id=2465554338","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2465554338?lang=zh_cn&edition=full","pubTime":"2024-09-05 08:02","pubTimestamp":1725494579,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息整理，民生健康于9月5日将有2139.33万股限售股份解禁，为公司首发原股东限售股份，占公司总股本6.0%。最近一年内，该股累计解禁459.3万股，占总股本的1.29%。本次解禁后，公司还有2.46亿股限售股份，占总股本69.0%。民生健康主营业务：维生素与矿物质类非处方药品和保健食品研发、生产、销售。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024090500006328.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2464837419","title":"民生健康(301507.SZ)2139.33万股限售股将于9月5日上市流通","url":"https://stock-news.laohu8.com/highlight/detail?id=2464837419","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2464837419?lang=zh_cn&edition=full","pubTime":"2024-09-02 21:51","pubTimestamp":1725285089,"startTime":"0","endTime":"0","summary":"智通财经APP讯，民生健康(301507.SZ)公告，公司首次公开发行前已发行股份本次解除限售数量为2139.33万股，占公司总股本的6.00%，上市流通日期为2024年9月5日(星期四)。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1178386.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507","BK0239"],"gpt_icon":0},{"id":"2463212981","title":"民生健康（301507）2024年中报简析：营收净利润同比双双增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2463212981","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463212981?lang=zh_cn&edition=full","pubTime":"2024-08-30 06:36","pubTimestamp":1724970996,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期民生健康发布2024年中报。根据财报显示，民生健康营收净利润同比双双增长。截至本报告期末，公司营业总收入3.97亿元，同比上升8.06%，归母净利润7726.94万元，同比上升10.3%。其中，毛利率60.43%，同比减1.8%，净利率19.44%，同比增2.08%，销售费用、管理费用、财务费用总计1.3亿元，三费占营收比32.74%，同比减3.71%，每股净资产4.25元，同比增71.05%，每股经营性现金流0.29元，同比减2.87%，每股收益0.22元，同比减15.38%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024083000007539.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2463497800","title":"图解民生健康中报：第二季度单季净利润同比增24.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2463497800","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2463497800?lang=zh_cn&edition=full","pubTime":"2024-08-29 01:57","pubTimestamp":1724867879,"startTime":"0","endTime":"0","summary":"证券之星消息，民生健康2024年中报显示，公司主营收入3.97亿元，同比上升8.06%；归母净利润7726.94万元，同比上升10.3%；扣非净利润7455.73万元，同比上升14.42%；其中2024年第二季度，公司单季度主营收入1.63亿元，同比上升11.51%；单季度归母净利润1839.71万元，同比上升24.48%；单季度扣非净利润1748.98万元，同比上升70.44%；负债率11.43%，投资收益246.68万元，财务费用-1181.42万元，毛利率60.43%。财报数据概要请见下图: 以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082900002429.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0},{"id":"2462498445","title":"民生健康最新公告：拟推350万股限制性股票激励计划","url":"https://stock-news.laohu8.com/highlight/detail?id=2462498445","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462498445?lang=zh_cn&edition=full","pubTime":"2024-08-28 23:41","pubTimestamp":1724859664,"startTime":"0","endTime":"0","summary":"民生健康公布2024年限制性股票激励计划，本计划拟向激励对象授予的第二类限制性股票总量为350.00万股，约占本计划公告时公司股本总额的0.98%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800045229.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","301507"],"gpt_icon":0},{"id":"2462284460","title":"民生健康(301507.SZ)发上半年业绩，净利润7726.94万元，同比增长10.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462284460","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462284460?lang=zh_cn&edition=full","pubTime":"2024-08-28 23:28","pubTimestamp":1724858896,"startTime":"0","endTime":"0","summary":"智通财经APP讯，民生健康(301507.SZ)发布2024年半年度报告，报告期内公司实现营业收入3.97亿元，同比增长8.06%;归属于上市公司股东的净利润7726.94万元，同比增长10.30%;归属于上市公司股东扣除非经常性损益净利润7455.73万元，同比增长14.42%;基本每股收益0.22元/股。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1174183.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["301507"],"gpt_icon":0},{"id":"2462611624","title":"民生健康最新公告：上半年净利润7726.94万元 同比增长10.30%","url":"https://stock-news.laohu8.com/highlight/detail?id=2462611624","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2462611624?lang=zh_cn&edition=full","pubTime":"2024-08-28 22:21","pubTimestamp":1724854883,"startTime":"0","endTime":"0","summary":"民生健康发布2024年半年度报告，报告期内，公司实现营业收入3.97亿元，较上年同期增长8.06%；归属于上市公司股东的净利润7726.94万元，较上年同期增长10.30%。以上内容为证券之星据公开信息整理，由智能算法生成，不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2024082800043968.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["301507"],"gpt_icon":0}],"profile":{"ret":0,"listingDate":"2023-09-05","address":"浙江省杭州市临平区东湖街道新天路101号","stockEarnings":[{"period":"1week","weight":-0.0484},{"period":"1month","weight":0.0552},{"period":"3month","weight":0.0292},{"period":"6month","weight":0.0222},{"period":"1year","weight":-0.2766},{"period":"ytd","weight":-0.1823}],"companyName":"杭州民生健康药业股份有限公司","boardCode":"AI0027","perCapita":"4174股","boardName":"医药制造业","registeredCapital":"35655万元","compareEarnings":[{"period":"1week","weight":-0.0352},{"period":"1month","weight":0.0399},{"period":"3month","weight":0.1567},{"period":"6month","weight":0.056},{"period":"1year","weight":0.0917},{"period":"ytd","weight":0.1196}],"survey":" 杭州民生健康药业股份有限公司的主营业务是集维生素与矿物质类非处方药品和保健食品研发、生产、销售。公司的主要产品是维生素与矿物质补充剂系列产品和益生菌系列产品；经过十余年的行业深耕，公司构建了覆盖全国的终端销售网络体系，拥有较强的品牌知名度和美誉度。公司主打品牌“21金维他”，2019年上榜“健康中国品牌榜”西普金·奖锐榜，2020年上榜“健康中国·品牌榜”西普金奖药品榜，2021年度入选“2020-2021年健康产业·品牌发展指数·TOP品牌”。","serverTime":1731820702165,"listedPrice":10,"stockholders":"26480人(较上一季度减少2.78%)","compareStock":{"symbol":"000001.SH","name":"上证指数"}},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.1","shortVersion":"4.29.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"民生健康,301507,民生健康股票,民生健康股票老虎,民生健康股票老虎国际,民生健康行情,民生健康股票行情,民生健康股价,民生健康股市,民生健康股票价格,民生健康股票交易,民生健康股票购买,民生健康股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"民生健康(301507)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供民生健康(301507)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}